Brazilin attenuates methylglyoxal‑induced endothelial injury by enhancing eIF5A hypusination and inhibiting the AMPK/mTOR‑mediated autophagy/apoptosis axis <i>in vitro</i> and <i>in vivo</i>

Methylglyoxal (MGO), a glycolytic metabolic byproduct and major precursor of advanced glycation end products (AGEs), accumulates and is critically involved in diabetes, particularly in diabetic vascular complications. In endothelial cells (ECs), MGO has been implicated in oxidative stress and inflammatory responses, and it can further induce autophagy and apoptosis. Brazilin (BZ), a natural compound, confers cytoprotection by allosterically activating deoxyhypusine hydroxylase (DOHH), thereby enhancing eukaryotic initiation factor 5A (eIF5A) hypusination, a distinctive post‑translational modification. Although BZ can mitigate vascular inflammation and regulate autophagy and apoptosis, its effects on MGO‑induced autophagy and apoptosis and the underlying mechanism remain elusive. In the present study, it was demonstrated that BZ pretreatment conferred cytoprotection by targeting DOHH and the downstream eIF5A signaling cascade, thereby suppressing activation of the AMP‑activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) signaling pathway. Moreover, 3‑methyladenine (3‑MA) and Compound C strengthened the inhibitory effect of BZ on MGO‑induced autophagy and apoptosis. By contrast, ciclopirox, a specific inhibitor of DOHH, abolished the BZ‑mediated suppression of MGO‑induced cellular responses. The in vivo experiments further confirmed that BZ suppresses MGO‑triggered autophagy and apoptosis. Using db/db mice to mimic the diabetic microenvironment, it was further found that DOHH inhibition reversed the BZ‑mediated suppression of autophagy and apoptosis. Collectively, the findings of the present study reveal a DOHH/eIF5A‑AMPK/mTOR axis through which BZ antagonizes MGO‑induced autophagy and apoptosis, shedding new light on the pharmacological mechanism of BZ and underscoring its therapeutic potential for diabetic vascular complications.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Medicine
Published
2026-07-30
DOI
https://doi.org/10.3892/ijmm.2026.5944
Primary Topic
Polyamine Metabolism and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Brazilin attenuates methylglyoxal‑induced endothelial injury by enhancing eIF5A hypusination and inhibiting the AMPK/mTOR‑mediated autophagy/apoptosis axis in vitro and in vivo

Jingcan You, Liang Yu, Junjing Xiong, Liqun Wang et al.
International Journal of Molecular Medicine
Polyamine Metabolism and Applications
article

Brazilin attenuates methylglyoxal‑induced endothelial injury by enhancing eIF5A hypusination and inhibiting the AMPK/mTOR‑mediated autophagy/apoptosis axis in vitro and in vivo

Jingcan You, Liang Yu, Junjing Xiong, Liqun Wang, Mao Luo, Jianbo Wu, Youkun Zheng, Haiyang Li, Jinxiang Chen
article en

Abstract

Methylglyoxal (MGO), a glycolytic metabolic byproduct and major precursor of advanced glycation end products (AGEs), accumulates and is critically involved in diabetes, particularly in diabetic vascular complications. In endothelial cells (ECs), MGO has been implicated in oxidative stress and inflammatory responses, and it can further induce autophagy and apoptosis. Brazilin (BZ), a natural compound, confers cytoprotection by allosterically activating deoxyhypusine hydroxylase (DOHH), thereby enhancing eukaryotic initiation factor 5A (eIF5A) hypusination, a distinctive post‑translational modification. Although BZ can mitigate vascular inflammation and regulate autophagy and apoptosis, its effects on MGO‑induced autophagy and apoptosis and the underlying mechanism remain elusive. In the present study, it was demonstrated that BZ pretreatment conferred cytoprotection by targeting DOHH and the downstream eIF5A signaling cascade, thereby suppressing activation of the AMP‑activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) signaling pathway. Moreover, 3‑methyladenine (3‑MA) and Compound C strengthened the inhibitory effect of BZ on MGO‑induced autophagy and apoptosis. By contrast, ciclopirox, a specific inhibitor of DOHH, abolished the BZ‑mediated suppression of MGO‑induced cellular responses. The in vivo experiments further confirmed that BZ suppresses MGO‑triggered autophagy and apoptosis. Using db/db mice to mimic the diabetic microenvironment, it was further found that DOHH inhibition reversed the BZ‑mediated suppression of autophagy and apoptosis. Collectively, the findings of the present study reveal a DOHH/eIF5A‑AMPK/mTOR axis through which BZ antagonizes MGO‑induced autophagy and apoptosis, shedding new light on the pharmacological mechanism of BZ and underscoring its therapeutic potential for diabetic vascular complications.

International Journal of Molecular MedicineVol. 58(4)
Southwest Medical University (CN)
Zero hunger
Openalex Percentile: Top 15%
Polyamine Metabolism and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.